Translational enhancement of HCV RNA genotype 1b by 3′-untranslated and envelope 2 protein-coding sequences  by Morikawa, Kenichi et al.
lsevier.com/locate/yviroVirology 345 (200Translational enhancement of HCV RNA genotype 1b by 3V-untranslated
and envelope 2 protein-coding sequences
Kenichi Morikawa, Takayoshi Ito *, Hisako Nozawa, Momoko Inokuchi, Manabu Uchikoshi,
Takeshi Saito, Keiji Mitamura, Michio Imawari
The Second Department of Internal Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan
Received 27 June 2005; returned to author for revision 10 August 2005; accepted 4 October 2005
Available online 14 November 2005Abstract
HCV RNA has a unique regulatory mechanism for translation. The X region of 3V-UTR and core-coding sequence regulate HCV
translation. In this study, we clarified that the entire 3V-UTR also enhances HCV translation, and the envelope-coding sequence of HCV
genotype 1b increases degree of this enhancement. In the luciferase reporter assay using rabbit reticulocyte lysates, translational
enhancement by 3V-UTR with core to E2 regions was 25-fold higher when compared with control RNA lacking the 3V-UTR. Presence of
the entire E2 sequence was important for this enhancement. This phenomenon was not due to transcript stability, and envelope protein alone
did not affect translation. E2-coding sequence of genotype 1a had no effect on translation. We observed the same results in animal cell
culture systems using bicistronic RNA. Structural protein-coding sequences and 3V-UTR of HCV RNA regulate viral translation, and a target
for antiviral agents may be present in these regions.
D 2005 Elsevier Inc. All rights reserved.Keywords: Hepatitis C virus; Internal ribosome entry site; Translation; HCV 3V-UTR; E2Introduction
Most eukaryotic mRNAs contain a cap structure at the 5V-end
and a poly (A) tail at the 3V-end. Individually or in concert, these
structures play essential roles in regulating translation (Sachs et
al., 1997). Association of mRNAs with a specific RNA-binding
protein and communication between both ends of the RNA
sequence synergistically stimulate translation initiation (Sachs
and Buratowski, 1997). In yeasts, the poly (A) tail-binding
protein (Pab1p) at the 3V-end associates with eIF4G, a subunit of
eIF4F, which binds to the 5V-end cap, thus stimulating translation
in vitro (Tarun and Sachs, 1996; Tarun et al., 1997). In humans,
interaction between the 5V- and 3V-ends similarly requires poly
(A)-binding protein (PABP) at the 3V-end and PABP-interacting0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.10.001
Abbreviations: HCV, hepatitis C virus; IRES, internal ribosome entry site;
PTB, polypyrimidine-tract-binding protein; UTR, untranslated region; LUC,
luciferase; RRL, rabbit reticulocyte lysates; IVT, in vitro translation; CAT,
chloramphenicol acetyltransferase.
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E-mail address: tito@med.showa-u.ac.jp (T. Ito).protein (PAIP)-1 at the 5V-end (Craig et al., 1998; Tarun and
Sachs, 1995). These observations suggest that circularization of
mRNAs via a cap structure, cap binding proteins (e.g., eIF4E),
PABP, and a poly (A) tail is important for efficient translation
(the closed-loop model) (Jacobson, 1996). In contrast, some
cellular and viral RNAs are translated in cap-independent
manner because of their highly structured and relatively long
5V-untranslated region (UTR) (Gan et al., 1998; Iizuka et al.,
1995; Jackson et al., 1995; Macejak and Sarnow, 1991). These
structured cis elements constitute an internal ribosome entry site
(IRES) that promotes internal initiation of translation.
Hepatitis C virus (HCV), which causes a variety of liver
diseases in humans (Saito et al., 1990; Tsukuma et al., 1993),
undergoes translation in an IRES-dependent manner, as do
picorna viruses (Fukushi et al., 1994; Honda et al., 1996;
Kamoshita et al., 1997; Rijnbrand et al., 1995; Tsukiyama-
Kohara et al., 1992; Wang et al., 1993). At the other end of the
HCV RNA, the 3V-UTR does not contain a poly (A) tail but a
poly (U/C) stretch followed by a highly conserved X region at
the 3V-end (Kolykhalov et al., 1996; Tanaka et al., 1995). This X6) 404 – 415
www.e
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of HCV RNA (Ito and Lai, 1999; Ito et al., 1998). Several
investigations have suggested possible functions of the poly (U/
C) stretch and have identified other cellular proteins binding to
the 3V-UTR of HCV RNA [e.g., La (Spangberg et al., 1999,
2001; Wood et al., 2001), HuR (Spangberg et al., 2000), hnRNP
C (Chung and Kaplan, 1999; Gontarek et al., 1999; Hahm et al.,
1998), and L22 (Wood et al., 2001)]. Polypyrimidine-tract-
binding protein (PTB) binds both the 5V-UTR and the X region.
The sequence and structure of stem-loop (SL) 2 and SL3, which
are binding domains in the X region, are critical for enhancement
of HCV translation (Ali and Siddiqui, 1995; Ito and Lai, 1997;
Ito et al., 1998). These results suggest that protein–RNA
interaction between cellular proteins and the X sequence
regulates HCV translation by a mechanism similar to the
closed-loop model.Fig. 1. Hepatitis C virus (HCV)-luciferase (LUC) chimeric RNAs and their transla
plasmid (pHCV-5VL3V) containing the HCV 5V-untranslated region (UTR), core, LU
core-to-E1 region (pHCV-5VCE1L3V), or core-to-E2 region (pHCV-5VCE1E2L3V)
ribosomal entry site (IRES; nt 1 to 418), LUC, and the 3V-UTR (pHCV-IRES-L3
restriction enzymes, a series of HCV-LUC chimeric RNAs were synthesized by T7
respectively. Similar RNAs lacking the 3V-UTR (IRES-L, 5VCL, 5VCE1L, and 5VC
gene was inserted between the T7 protein and the 5V-UTR of pHCV-5VCE1E2L3V to
of HCV chimeric RNAs electrophoretically separated on 10% or 15% SDS-polyac
mM KCl in the presence of canine pancreatic microsomal membranes. Arrows in
Computer images were generated using Presto! Page Manager (version. 4.20.06,Much remains to be determined regarding the functions of
these interactions; one group reported down-regulation of HCV
RNA translation by the entire 3V-UTR (Murakami et al., 2001).
Several groups have demonstrated that the presence or absence
of the 3V-UTR sequence did not affect translation efficiency in
HCV genotype 1a and 2b RNA (Fang and Moyer, 2000; Imbert
et al., 2003; Kong and Sarnow, 2002). Furthermore, viral
proteins and their coding sequences also are involved in HCV
translation. HCV core protein interacts with viral sense RNA to
suppress viral translation (Shimoike et al., 1999; Zhang et al.,
2002), while a pyrimidine-rich sequence in the core region of
HCV RNA suppresses translation (Ito and Lai, 1999). These
results indicate that viral RNA, viral protein, and host cellular
factors are involved in the regulation of HCV RNA translation.
In the present study, we showed that the entire 3V-UTR also
enhanced HCV translation in a reporter assay using in vitro andtion products. (A) Schematic view of HCV-LUC chimeric RNAs. A T7-based
C, and 3V-UTR was constructed from pCV-J4L6S. HCV core (pHCV-5VCL3V),
was inserted upstream of LUC. A plasmid containing the entire internal
V) was also constructed. After linearization of these plasmids by appropriate
RNA polymerase to generate IRES-L3V, 5VCL3V, 5VCE1L3V, and 5VCE1E2L3V,
E1E2L) were also synthesized. The chloramphenicol acetyltransferase (CAT)
generate CAT 5VCE1E2L3V. (B) In vitro translation (IVT) products of a series
rylamide gels. IVT was carried out in rabbit reticulocyte lysates (RRL) at 120
dicate putative molecular weights of HCV core, E1, E2, and LUC proteins.
NewSoft Technology, Taipei, Taiwan).
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genes. We also demonstrated that inclusion of the envelope
RNA element in these transcripts further increases 3V-UTR-
mediated enhancement. Structural protein-coding sequence in
concert with both UTRs may play an important role in
regulating HCV translation. Furthermore, this phenomenon
was not observed in HCV genotype 1a but in genotype 1b, thus
suggesting that different HCV genotypes have different viral
translation efficiencies, even if the amount of HCV RNA is
identical.Fig. 2. Relative LUC activity of IVT products of various HCV RNAs with (w/) or wi
and (D to F) HCV 5VCE1E2L3V RNAs were used as templates for IVT with or witho
which was performed at 80 mM KCl. One IVT reaction was performed in wheat
Columns and bars represent the mean and standard error of the mean for two sets of
HCV 3V-UTR was significantly enhanced. *P < 0.05; **P < 0.01.Results
Entire 3V-UTR enhances translation of HCV RNA in RRL
together with envelope-coding sequences
In order to investigate the roles of HCV structural proteins
and/or RNA elements in translational regulation of HCV RNA
by the 3V-UTR, we generated a series of HCV chimeric RNAs,
as shown in Fig. 1A. The 3V-UTR of HCV consists of three
parts: a variable region, a poly (U/C) stretch, and the X regionthout (w/o) 3V-UTR. (A) HCV IRES-L3V, (B) HCV 5VCL3V, (C) HCV 5VCE1L3V,
ut the 3V-UTR. Reactions were performed in RRL at 120 mM KCl, except (E),
germ extract (F). LUC activity without the 3V-UTR is set arbitrarily at 100%.
triplicate experiments. Asterisks indicate that translation of these RNAs with the
Fig. 4. Trans-acting effects of HCV structural protein on HCV RNA
translation. HCV 5VCE1E2 RNA transcript was added to RRL containing
HCV IRES-L3V or HCV IRES-L. IVT was carried out in RRL at 120 mM KCl.
Relative LUC activity of translation products is shown. LUC activity of HCV
IRES-L was arbitrarily set at 100%. Columns and bars represent the mean and
standard error of the mean for triplicate experiments. Asterisks indicate that
translation with 3V-UTR was significantly enhanced. **P < 0.05.
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performed an IVT experiment using HCV chimeric RNAs
containing the entire 3V-UTR derived from an HCV-1b strain
(pCV-J4L6S) (Yanagi et al., 1998) at 120 mM KCl. When we
compared the translation efficiency in RRL between HCV
5VCL3Vwith and without the entire 3V-UTR, RNA having the
entire 3V-UTR showed a 2- to 3-fold enhancement of translation
(Figs. 1B and 2B). This is consistent with previous observations
(Ito et al., 1998). The same experiment using HCV IRES-L3V
RNA gave similar results (Figs. 1B and 2A). When transcripts
HCV 5VCE1L3V and 5VCE1E2L3V were used as templates, we
added canine pancreatic microsomal membranes into RRL in
order to process and glycosylate each IVT product. Appropriate
molecular size after processing and glycosylation was con-
firmed on SDS-PAGE (Fig. 1B). IVT studies with HCV
5VCE1L3V and 5VCE1E2L3V RNAs revealed that 3V-UTR-
mediated enhancement of translation was 8- and 25-fold higher,
respectively (Figs. 1B, 2C and D). These results indicate that
envelope-coding sequences, particularly E2, act as enhancers
for HCV translation in concert with the 3V-UTR. We also carried
out similar experiments with HCV 5VCE1E2L3V at a different
salt concentration (80 mM KCl). Translational enhancement by
HCV envelope and 3V-UTR was only 8-fold at 80 mM KCl,Fig. 3. Primer extension study of intact HCV-LUC chimeric RNAs remaining in
rabbit reticulocyte lysates (RRL) during IVT. (A) Calibration of primer extension
experiments. Decreasing amounts of HCV 5VCE1E2L3VRNAs (3, 2, 1, 0.5, 0.25,
and 0.125 Ag) are used as templates for primer extension reaction using 5V-UTR
primer. Completely extended products (207 nt) are shown on a 6% polyacryl-
amide gel after autoradiography. (B) RNA stability of HCV 5VCE1E2L3V (left)
and HCV5VCE1E2L (right) RNAs in RRL. Each RNA (2 Ag) was incubated with
RRL.At 0, 30, 60, and 90min after IVT, RNAs remaining in RRLwere extracted,
and half of those extracted at each time point were used for primer extension.
Arrows indicate extended products (207 nt) and 32P-labeled primer.indicating that this effect is dependent on high salt concentra-
tions (Fig. 2E). When we carried out the same experiment using
wheat germ extracts, translational enhancement was only 2-fold
(Fig. 2F). These results suggest that the enhancement effect is
correlated with specific factors in RRL.
Enhancement by 3V-UTR on HCV 5VCE1E2L3V RNA translation
is not the result of RNA stabilization
We next investigated whether translational enhancement by
the 3V-UTRwas due to stabilization of viral RNA.Wemonitored
the degradation kinetics of HCV 5VCE1E2L3V RNA and the
same RNA lacking the 3V-UTR (HCV 5VCE1E2L) in RRL. To
quantitate remaining intact RNAs, we performed a primer
extension study using a primer complementary to the 5V-UTR
of HCVRNA. Primer extension was performed using conditions
under which primer-extended products linearly reflected the
amounts of RNA (HCV 5VCE1E2L3V) (Fig. 3A). Fig. 3B shows
that the kinetics of RNA degradation were similar between the
two RNAs, indicating that the RNAs had comparable stability
and that translational enhancement by the 3V-UTR together
with the envelope region did not result from RNA
stabilization. We performed the same experiment three times
and obtained the same conclusion from each experiment.
IVT products of HCV structural protein added in trans do not
affect HCV translation
In order to investigate the possible mechanism of this
translational enhancement, we investigated whether IVT products
of the envelope affectedHCV translation.When theHCV5VCE1E2
transcript was added in a trans manner to the IVT reaction mixture
containing HCV IRES-L3V RNA, translational enhancement by
HCV 3V-UTR was comparable to that of HCV IRES-L3V RNA
alone (Fig. 4). This suggests that envelope protein itself does not
play an important role in this translational enhancement.
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3V-UTR-mediated enhancement
In order to confirm that RNA elements of the HCV envelope
further increase the 3V-UTR-mediated enhancement of HCV
translation, we constructed a mutant HCV 5VCE1E2L3V RNA
containing a stop codon at the N-terminus of the E1 region [HCV
5VCE1E2L(FS)3V] and performed the same IVTexperiment as above
(Fig. 5A). This mutant RNA containedmost of the same elements as
HCV 5VCE1E2L3V but did not generate E1 to LUC proteins during
IVT. Fig. 5B shows that the translational enhancement of HCV
5VCE1E2L(FS)3V RNA by the HCV 3V-UTR is similar to that ofFig. 5. (A) Scheme of stop codon insertion at N-terminus of E1 region in HCV 5
blunted with S1 nuclease. In vitro transcription was then performed using T7 R
synthesized transcripts, HCV 5VCE1E2L(FS)3V and 5VCE1E2L(FS), had a stop codo
LUC after IVT. (B) IVT products of a series of HCV chimeric RNAs [HC
electrophoretically separated on 12.5% or 15% polyacrylamide gels. IVT was carrie
membranes. Arrows indicate putative molecular weights of HCV core, E1, E2, L
generated by Presto! Page Manager (version. 4.20.06, NewSoft Technology, Taipeiwild-type RNA (HCV 5VCE1E2L3V). These results suggest that
translational enhancement by HCV 3V-UTR together with the
envelope-coding sequence requires cis-acting elements.
Mapping of region responsible for translational enhancement
in HCV E2
In an effort to further dissect the sequence requirements of the
envelope region in translational enhancement, we created a series
truncated E2 regions for IVT studies as E2 is a critical region for
this enhancement (Fig. 2). We constructed a series of truncated
E2 regions in the HCV 5VCE1E2L3V transcript. The 3V-end of E2VCE1E2L3V RNA. The plasmid pHCV 5VCE1E2L3V was digested by NsiI and
NA polymerase following kination and self-ligation of plasmids. The newly
n at the N-terminus of the E1 region and did not express the region from E1 to
V 5VCE1E2L(FS)3V, 5VCE1E2L(FS), 5VCE1E2L3V, and 5VCE1E2L RNAs]
d out in RRL at 120 mM KCl in the presence of canine pancreatic microsomal
UC, and unprocessed core-E1 (N-terminus) proteins. Computer images were
, Taiwan).
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L3V, from 1965 to 2583 (nt); HCV 5VCE1E2(del618)L3V, and
from 1708 to 2583 (nt); HCV 5VCE1E2(del875)L3V (Fig. 6A). In
IVT, all of the E2 deletion mutants resulted in marginal
translational enhancement by the 3V-UTR (Figs. 6B–D). This
suggests that presence of the entire E2 RNA sequence is
important for the translational enhancement.Fig. 6. Mapping of E2 region responsible for translational enhancement. (A) A
synthesized for IVT experiments in RRL at 120 mM KCl. Relative LUC activities o
5VCE1E2(del618)L3V, (D) HCV5VCE1E2(del875)L3V, and (E) HCV 5VCE1E2L3V RN
each RNAwithout 3V-UTR was arbitrarily set at 100%. Columns and bars represent t
that the translation of these RNAs by HCV 3V-UTR was significantly enhanced. *PTranslational enhancement by the 3V-UTR with envelope region
in animal cell cultures
In order to examine whether translational enhancement by
the 3V-UTR together with HCV envelope region also occurs in
intact animal cells, we performed RNA transfection experi-
ments in Huh7 (Nakabayashi et al., 1982), HeLa (Gey et al.,series of truncations of the E2 region in HCV 5VCE1E2L3V transcripts were
f the translation products are shown. (B) HCV 5VCE1E2(del302)L3V, (C) HCV
As were used as templates for IVTwith or without the 3V-UTR. LUC activity of
he means and standard errors of two sets of triplicate studies. Asterisks indicate
< 0.05; **P < 0.01.
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5VCE1E2L3V RNA with and without the 3V-UTR. Translation
of HCV 5VCE1E2L3V RNA was about 14-fold higher than that
of the RNA without the 3V-UTR in Huh7 cells (Fig. 7C).
Translational enhancement by the 3V-UTR was also observed
in HeLa cells (4- to 5-fold) and in HepG2 cells (6- to 7-fold),
but the degree of enhancement was lower than in Huh7 cells
(Figs. 7A–C). These results confirmed that the 3V-UTR
enhances translation of HCV RNA together with the HCV
envelope region in intact cells, although the degree of
enhancement was lower than that seen in IVT studies.
Furthermore, we constructed CAT5VCE1E2L3V RNA (Fig.
1A) and used a bicistronic translation model with CAT and
LUC reporters. In Huh7, enhancement of LUC expression by
the 3V-UTR was the same as was observed with the
monocistronic transcript. CAT expression was unchanged
with or without 3V-UTR (Fig. 7D).
Enhancement by 3V-UTR together with envelope region was
marginal for genotype 1a HCV RNA translation
The HCV envelope region has heterogeneity among isolates
and genotypes. We compared translational enhancement using
envelope RNA derived from genotype 1a (Yanagi et al., 1997)Fig. 7. HCV 3V-UTR enhances HCV translation together with envelope region in anim
IVT is compared with that of RNA without (w/o) 3V-UTR in (A) HeLa cells, (B)
individually transfected into cells. Relative LUC activity in cell lysates is shown. LU
of the 3V-UTR together with the envelope region in Huh7 cells from bicistronic RNA
expression ratio is shown. LUC/CAT ratio of CAT 5VCE1E2L was arbitrarily set at
triplicate experiments. Asterisks indicate that translation with the 3V-UTR was signand 1b (Yanagi et al., 1998) HCV RNAs in RRL. Translation
of the HCV 1a [HCV 1a 5VCE1E2L3V] transcript was enhanced
by only 3.5-fold, even in the presence of the envelope region
(Fig. 8), indicating that the envelope RNA element of HCV
genotype 1a does not contribute to 3V-UTR-mediated enhance-
ment. These results indicate that different HCV RNA
genotypes have different translation efficiencies, even if the
amount of HCV RNA is identical.
Discussion
Lacking a cap structure at the 5V-end and a poly (A) tail at
the 3V-end, translation of HCV RNA is regulated differently
than most eukaryotic mRNAs and other viral RNAs. HCV
RNA is translated in an IRES-dependent manner, similarly to
picorna viruses (Fukushi et al., 1994; Honda et al., 1996;
Kamoshita et al., 1997; Rijnbrand et al., 1995; Tsukiyama-
Kohara et al., 1992; Wang et al., 1993); it also has an X-
region at the 3V-end (Kolykhalov et al., 1996; Tanaka et al.,
1995). The X region enhances IRES-dependent translation of
HCV RNA (Ito et al., 1998; Michel et al., 2001), and this
mechanism is thought to be related to the interaction between
PTB and viral RNA (Ito and Lai, 1997, 1999). We showed
that the entire 3V-UTR also enhances HCV translation by 2- toal cell cultures. Relative LUC expression of HCV 5VCE1E2L3V RNA (w/) after
HepG2 cells, and (C) Huh7 cells. Two types of RNA transcript (10 Ag) were
C activity for each RNAwithout 3V-UTR was arbitrarily set at 100%. (D) Effects
s. CAT 5VE1E2L3V or CAT 5VCE1E2L was transfected in Huh7 cells. LUC/CAT
1.0. Columns and bars represent the mean and standard error of the mean for
ificantly enhanced. *P < 0.05; **P < 0.01.
Fig. 8. Translational enhancement by 3V-UTR together with envelope region
was marginal for genotype 1a HCV RNA. HCV 1a-LUC chimeric RNAs with
(HCV 1a 5VCE1E2L3V) and without 3V-UTR (HCV 1a 5VCE1E2L) were
synthesized by T7 RNA polymerase. Relative LUC activities of IVT products
in RRL for the two RNAs are shown. LUC activity of IVT products of HCV
1a 5VCE1E2L was arbitrarily set at 100%. Columns and bars represent the
means and standard errors of two sets of triplicate studies. Asterisks indicate
that translation of these RNAs by HCV 3V-UTR was significantly enhanced.
*P < 0.05.
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previous study on the HCV X region (Ito et al., 1998).
However, the mechanism of this enhancement remains to be
clarified. Two groups have reported that the 3V-UTR sequence
does not affect translation (Fang and Moyer, 2000; Imbert et
al., 2003). Another group has shown down-regulation of HCV
RNA translation by the entire 3V-UTR (Murakami et al.,
2001), which contradicts a previous report (Ito et al., 1998).
This discrepancy may depend on the HCV genotype used
for the constructs in the studies. Two groups reporting that the
X region at the 3V-end of HCV enhances IRES-dependent
translation used genotype 1b isolates (Ito et al., 1998; Michel
et al., 2001). Two other groups reporting that 3V-UTR sequence
did not affect translation used genotype 1a isolates (Fang and
Moyer, 2000; Imbert et al., 2003). The group showing down-
regulation of HCV RNA translation by the entire 3V-UTR used
a genotype 2b strain (Murakami et al., 2001). A transcript of
HCV 1a 5VCE1E2L3V in the reporter assay gave only a 3.5-fold
enhancement of HCV translation, even in the presence of the
envelope region. This is the same as the translational
enhancement seen with the 3VUTR alone, indicating that the
envelope RNA element of genotype 1a does not contribute to
3VUTR-mediated enhancement.
HCV isolates are classified into several genotypes depend-
ing on their sequences, and interferon sensitivity differs
among the genotypes. Each HCV isolate also has different
pathogenecity in patients with chronic HCV infection. Some
patients infected with high HCV RNA titers do not show any
liver injury, while others with low HCV RNA titers have
advanced liver disease. This is thought to be because CTL
responses against HCV vary, while protein expression levels
and HCV RNA translation efficiencies of individual HCV
RNA differ among HCV isolates. Viral proteins and coding
sequences may also be involved in HCV translation. HCV
core protein, a structural protein, has been reported to interactwith viral sense RNA and suppress viral translation (Shi-
moike et al., 1999; Zhang et al., 2002). The pyrimidine-rich
sequence of the HCV core region also regulates HCV
translation (Ito and Lai, 1999; Wang et al., 2000). Our data
suggest that the HCV envelope protein and/or RNA elements
may provide an additional factor for translational enhancement
in the presence of the 3V-UTR.
All IVT reactions in this study were carried out at 120 mM
KCl in RRL. When translation was performed at 80 mM KCl,
translational enhancement was marginal. 5V-end-dependent
translation for most eukaryotic mRNAs is inhibited at 120
mM KCl in RRL, and transcripts having IRES are specifically
translated at this KCl concentration (Ito et al., 1998).
Translational enhancement by the 3V-UTR might be specific
for IRES-dependent translation of HCV RNA. This enhance-
ment was also marginal in wheat germ extracts, indicating that
cellular factors in RRL might specifically interact with viral
RNAs and/or proteins. The kinetics of HCV RNA degradation
during IVT were similar between HCV 5VCE1E2L3V RNAs
with or without the 3V-UTR, indicating that the two RNAs had
comparable stability. This is consistent with previous reports
(Fang and Moyer, 2000; Kong and Sarnow, 2002). In order to
estimate the kinetics of RNA degradation, we used a primer
extension experiment at the 5V-end of HCV RNA to know how
much the intact RNA, which contains the 5V-end without
degradation, remains.
Translational enhancement by the 3V-UTR was also ob-
served in animal cell culture systems. Translational efficiency
of HCV 5VCE1E2L3V was approximately 14-fold higher than
that of the same RNA lacking the 3V-UTR in Huh7 cells. This
degree of enhancement was less than that observed in the IVT
experiments at 120 mM KCl but was similar to that observed at
80 mM KCl. A previous report also showed that the
translational enhancement by the 3V-X region in Huh7 cells
(2- to 3-fold) was lower than that in RRL (5-fold) (Ito et al.,
1998). Factors present in animal cell culture systems may
inhibit the 3V-UTR-mediated enhancement, although these
factors remain unknown. Another possibility is that nonspecific
translation from the 5V-end of transcripts inhibits IRES-
dependent translation in intact cells, as occurs in IVT
experiments at 80 mM KCl in RRL. Translational enhancement
by the 3V-UTR in HeLa cells (4- to 5-fold) and HepG2 cells (6-
to 7-fold) was lower than in Huh7 cells. Huh7 cells, a human
hepatoma cell line, have recently been shown to support
replication of several HCV subgenomic replicons (Ikeda et al.,
2002; Kato et al., 2003; Lohmann et al., 1999). This cell line is
thought to possess replication factors for HCV RNA. However,
it is unclear why the translational enhancement differs among
the three cell lines. We speculate that Huh7 cells may also
possess factors that act on not only HCV replication but also
translation.
An RNA transfection experiment using bicistronic RNA
(CAT 5VCE1E2L3V) in Huh7 cells showed the same results as
for monocistronic RNA. This indicates that 5V-end-dependent
translation does not affect enhancement in a monocistronic
RNA system. When the HCV 5VCE1E2 transcript was added in
a trans manner to the IVT reaction mixture containing HCV
K. Morikawa et al. / Virology 345 (2006) 404–415412IRES-L3V, translational enhancement by HCV 3V-UTR was
only 2.5-fold. These results suggest that the IVT product of the
HCV envelope does not directly enhance HCV translation.
HCV 5VCE1E2L(FS)3V RNA contains nearly the same RNA
elements as HCV 5VCE1E2L3V RNA but does not translate the
E1 to LUC region during IVT because of a stop codon at the N-
terminus of the E1 region. The translational enhancement by
the 3V-UTR in HCV 5VCE1E2L(FS)3V RNA was similar to that
in HCV 5VCE1E2L3V RNA. These results indicate that
translational enhancement by the HCV 3V-UTR together with
the envelope region is due to cis-acting interaction between the
RNA elements.Fig. 9. Sequence alignment of 3V-end of HCV E2 region, the putative domain res
Alignment of 3V-end of E2 region [2281–2583 (nt)] among HCV 1b isolates, J4 (A
(AF483269). (B) Alignment of 3V-end of E2 region [2281–2583 (nt)] among other g
3b; Tr Kj (D49374), and 4a; ED43 (Y11604). Accession numbers of each isolate aThe present study suggests that the HCV envelope region,
particularly the E2-coding sequence, is essential for 3V-UTR-
mediated enhancement of HCV RNA translation. When we
used three deletion mutants of HCV 5VCE1E2L3V RNA for IVT
experiments, translational enhancement by the HCV 3V-UTR
was lower than that using HCV 5VCE1L3V RNAwhich does not
contain E2. From this conflicting result, the 5V terminus of E2
region may have inhibitory effect on HCV translation due to
unknown reasons. Change of the secondary structure might be
responsible for the inhibition. Further study is required to
clarify the mechanism. From these experiments, we suggest
that presence of the entire E2 sequence plays an important roleponsible for translational enhancement by 3V-UTR, among HCV isolates. (A)
F139594), K1-R1 (D50480), MD10-2 (AF165064), N (AF139594), and TR-1
enotypes, 1a; H77 (AF011751), 2a; MD2a-1 (AF238481), 3a; CB (AF046866),
re indicated.
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to 2583 (nts) may play an important role in the translational
enhancement.
Another interesting finding was that the HCV-1a E2
sequence did not enhance translation. Homology between the
303-nucleotide sequence of the 3V-end of HCV 1b E2 and that
of other genotypes is low (63.0–78.2%), while the same region
is relatively conserved among HCV 1b isolates (88–91%) (Fig.
9), indicating that enhancement by the E2 sequence is specific
to HCV genotype 1b. This study is the first report that HCV
E2-coding sequences are involved in the regulation of HCV 1b
translation. RNA–RNA and/or protein–RNA interactions may
change the secondary structure of HCV IRES in such a way as
to increase affinity for translation factors. The mechanism of
this enhancement remains unknown, and thus further investi-
gation is required.
In conclusion, the E2 protein-coding sequence is able to
enhance translation of HCV genotype 1b in a 3V-UTR-
mediated manner in both RRL and animal cell culture
systems. These results indicate that different genotypes of
HCV RNA exhibit different translation efficiencies, even if
the amount of HCV RNA is identical. Both structural
protein-coding sequences and the 3V-UTR of HCV RNA play
an important role in regulating viral translation and may be
targets for antiviral agents.
Materials and methods
Plasmid construction
A T7-based plasmid, pHCV-5VL, containing the HCV 5V-
UTR and the luciferase (LUC) gene as a reporter, was produced
from pCV-J4L6S (HCV-1b) (Yanagi et al., 1998) and pGL-basic
vector (Promega, WI, USA). Briefly, an HCV cDNA fragment
containing the T7 promoter and appropriate restriction enzyme
sites was amplified by polymerase chain reaction (PCR) using
pCV-J4L6S. After digestion with specific restriction enzymes,
gel-purified PCR products were subcloned into the pGL-basic
vector. The entire 3V-UTR cDNA containing XbaI and BamHI
sites was also amplified by PCR. The PCR product of 3V-UTR
was then subcloned into pCR 2.1, a TA cloning vector
(Invitrogen, Groningen, Netherlands). The resulting plasmid,
pCR 3V-UTR, was further digested with XbaI and BamHI and
subcloned into pHCV-5VL3V. We inserted one of a series of
cDNAs consisting of the HCV IRES (nt 1 to 342; pHCV IRES-
L3V), core (nt 1 to 914; pHCV 5VCL3V), core to E1 (nt 1 to 1492;
pHCV 5VCE1L3V), and core to E2 (nt 1 to 2583; pHCV
5VCE1E2L3V) regions of pCV-J4L6S upstream of LUC in
pHCV-5VL3V. Using the same strategy, we also prepared a
plasmid, pHCV 1a 5VCE1E2L3V, from pCV-H77C (HCV 1a-
strain) (Yanagi et al., 1997) for generation of HCV 1a-LUC
chimeric RNAs with (HCV 1a 5VCE1E2L3V) and without the 3V-
UTR (HCV 1a 5VCE1E2L).
In order to construct pCAT 5VCE1E2L3V for generation of
bicistronic RNAs, the chloramphenicol acetyltransferase
(CAT) gene obtained from pCAT3-basic vector (Promega)
was inserted upstream of the 5V-UTR in pHCV 5VCE1E2L3V.In vitro RNA transcription
Plasmids were linearized with the appropriate restriction
enzymes andwere used as templates to generate a series of HCV-
LUC chimeric RNAs with or without the 3V-UTR (Fig. 1A). In
vitro transcription was performed using T7 RNA polymerase
according to the manufacturer’s instructions (Promega).
In vitro translation
In vitro translation (IVT) was performed in micrococcal
nuclease-treated rabbit reticulocyte lysates (RRL; Flexi, Pro-
mega). Translation (25 Al) was carried out using 2 Ag of RNA as a
template, 10 Al of lysates, 0.5 U of RNase inhibitor (RNasin;
Promega), 2 mM dithiothreitol (DTT), amino acid mixture
lacking methionine (20 AM), 2 Al of [35S]-labeled methionine
(0.35 MBq/Al; Japan Radioisotope Association, Tokyo, Japan),
and 120 mM KCl in the presence of canine pancreatic
microsomal membranes (Promega). All reactions were carried
out in a water bath at 30 -C for 120 min. LUC activities of
translation products were measured as described below, and
products were separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) on 10 or 15% polyacryl-
amide gels. After drying, gels were exposed to radiographic film.
Primer extension
Two micrograms of various RNAs was incubated with RRL
under the same conditions as for IVT. Total RNAwas extracted
from the lysates at 0, 30, 60, and 90 min after the reaction using
Trizol reagent (Gibco BRL, NY, USA) and was analyzed by
primer extension using a [g-32P]-ATP end-labeled primer (5V-
GTTGATCCAAGAAAGGACCC-3V) complementary to the
5V-UTR of HCV RNA, as previously reported (Ito et al., 1998).
Cell culture and RNA transfection
Huh7 (Nakabayashi et al., 1982), HeLa (Gey et al., 1952),
and HepG2 (Skelly et al., 1979) cells were seeded in Dulbecco’s
Modified Eagle Medium (DMEM) on 35-mm tissue culture
dishes 24 h prior to transfection. Cells at 80% confluence were
transfected with RNA transcripts using DMRIE-C reagent
(Gibco BRL). Before RNA transfection, DMEM was removed,
and cells were washed with 2 ml of Opti-MEM (Gibco BRL).
Next, 10 Ag of RNA and 10 Al of DMRIE-C mixture in 1 ml of
Opti-MEM were added to culture dishes. After incubation at 37
-C for 4 h, the reaction mixture was removed followed by
addition of 2 ml of DMEM supplemented with 10% fetal bovine
serum (FBS). After 24 h of incubation at 37 -C, cells were
washed once with phosphate-buffered saline (PBS) and were
harvested with 125 Al of cell lysis buffer (Promega) for LUC
assays (de Wet et al., 1987).
LUC and CAT assays
LUC activity for 10 Al of IVT products was measured by
a Luminometer (Microtech, Chiba, Japan) 10 s after mixing
K. Morikawa et al. / Virology 345 (2006) 404–415414with 50 Al of luciferase assay reagent (Promega). Lysates of
transfected Huh7, HeLa, and HepG2 cells (representing
approximately 2.5105 cells) were centrifuged at 15,000
rpm in a 15-ml polypropylene conical tube for 5 min after
harvest with cell lysis buffer (Promega). Twenty microliters
of supernatant was mixed with 100 Al of luciferase assay
reagent, and LUC activity was measured for 10 s with the
Luminometer. For CAT assay, cellular lysates were incubated
at 60 -C for 10 min, and 100 Al of cell extract was mixed
with 15 Al of 0.25 M Tris–HCl (pH 7.4), 3 Al of [14C]
chloramphenicol (0.025 mCi/ml; Japan Radioisotope Asso-
ciation, Tokyo, Japan), and 5 Al of n-butyryl CoA (5 Ag/Al;
Promega). After incubation for 3 h at 37 -C, the mixture
was extracted with 500 Al of ethyl acetate (Wako Pure
Chemical Industries, Osaka, Japan) for thin-layer chroma-
tography (TLC). For TLC, the reaction mixture described
above was separated on silica plates using a chloroform:-
methanol (97:3) solvent system. Resolved reaction products
were detected by autoradiography. Each of the butylated
products was then scraped from the glass plates, and CAT
activity was determined using a scintillation counter.
Insertion of stop codon due to frameshift
Plasmid pHCV 5VCE1E2L3V was linearized by NsiI. After
digestion, the plasmid was treated with 50 U of S1 nuclease
(Ambion, TX, USA). After kination using 10 U of T4 PNK, 5
Al of 10 kination buffer, and 10 mM ATP, self-ligation was
performed using 1 U of T4 DNA ligase (Promega), 1 Al of
10 ligation buffer, 10 U of T4 PNK, and 10 mM ATP at 17
-C for 16 h. Sequence analysis of the ligated plasmid
confirmed that a UAA codon was inserted at the 5V-end in
the E1 region of pHCV 5VCE1E2L3V by the 1/+2 frameshift
[pHCV 5VCE1E2L(FS)3V].
Mapping of E2 region in HCV 5VCE1E2L3V
We constructed a series of truncated E2 regions among
HCV 5VCE1E2L3V transcripts. pHCV 5VCE1E2L3V was
linearized by the appropriate restriction enzyme. After
digestion, the 3V-end of E2 was truncated from 2281 to
2583 (nt); pHCV 5VCE1E2(del302)L3V, from 1965 to 2583
(nt); pHCV 5VCE1E2(del618)L3V, and from 1708 to 2583
(nt); pHCV 5VCE1E2(del875))L3V. Digested plasmids were
blunted with S1 nuclease (Ambion, Tx, USA) as described
above. After kination using T4 PNK, self-ligation was
performed using T4 DNA ligase (Promega) at 17 -C for
16 h. In vitro transcription was then performed as described
above.
Statistical analysis
Data from repeated experiments were averaged and
expressed as means T standard error of the mean. Effects of
the 3V-UTR on translation were analyzed by Student’s t test for
paired samples. P values of less than 0.05 were considered
statistically significant.Acknowledgments
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